C81.03
Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) is a rare type of Hodgkin lymphoma, characterized by the presence of abnormal lymphocytes called popcorn cells. When this condition affects the intra-abdominal lymph nodes—that is, the lymph nodes located within the abdominal cavity—it presents unique diagnostic and treatment considerations. NLPHL typically progresses slowly and tends to have a better prognosis compared to other forms of Hodgkin lymphoma. Understanding the nature of this disease can help patients better grasp their diagnosis and the importance of medical management.
Causes & Symptoms
Clinical Causes: The exact cause of NLPHL remains unknown, but it involves genetic mutations within lymphocytes (a type of white blood cell). There is no clear evidence linking NLPHL to environmental or lifestyle factors, though some theories suggest viral infections may play a role. Certain genetic predispositions might influence susceptibility, but research is ongoing. Immune system dysfunction could potentially contribute to the development of lymphomas, including NLPHL.
Key Symptoms: Painless swelling of lymph nodes in the abdomen, often discovered during routine examinations or imaging. Abdominal pain or discomfort, which may be persistent or intermittent. Unexplained weight loss over a short period. Fever, especially low-grade or intermittent fevers. Night sweats that are drenching and occur frequently. Fatigue and general feeling of weakness. Feeling of fullness or bloating due to enlarged lymph nodes pressing on surrounding structures.
Diagnostic & Treatment
Diagnosis Path: Physical examination focusing on identifying swollen lymph nodes in the abdomen. Imaging studies such as CT scans, PET scans, or ultrasound to visualize lymph node enlargement and assess the extent of spread. Lymph node biopsy: A surgical procedure to remove a tissue sample for microscopic examination, which confirms the presence of NLPHL. Histopathology: Microscopic analysis reveals characteristic popcorn-shaped lymphocytes, a hallmark of NLPHL. Immunohistochemistry: Special stains are used to differentiate NLPHL from other lymphomas and confirm diagnoses. Additional blood tests may support the overall assessment and guide treatment planning.
Treatment Protocols: Observation: In very early or indolent cases, periodic monitoring may be appropriate. Radiation therapy: Targeted radiation can effectively treat localized lymph node involvement. Chemotherapy: Regimens such as ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) are often employed for systemic disease or advanced cases. Immunotherapy: Monoclonal antibodies like rituximab may be used, especially for cases expressing CD20 markers. Combination therapies: A combination of chemotherapy and radiation might be recommended to optimize outcomes. Stem cell transplant: Considered in rare, relapsed, or refractory cases where conventional therapies have not been successful. Supportive care: Managing side effects of treatment and maintaining overall health is essential throughout therapy.
Clinical Advice & FAQs
Billing Guidance
Is C81.03 a billable ICD-10 code?
Yes, C81.03 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.03?
Clinical documentation must specify the nature of Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference